CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Biosenic SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Biosenic SA
Rue Granbonpre 11, Batiment H (bte 24)
Phone: +32 493097366p:+32 493097366 MONT-SAINT-GUIBERT, 1435  Belgium Ticker: BIOSBIOS
Business Summary
Biosenic SA formerly known as Bone Therapeutics SA is a Belgium-based company developing cell therapy products. The Company develops cell therapy products for the treatment and regeneration of bone tissue and bone reconstruction applications, osteonecrosis, ununited fractures, and maxillo-facial reconstruction. It is engaged in research, enable adult stem cell isolation, expansion, and osteogenic differentiation. The Company’s therapeutic area focus is bone diseases, with extensions to joint, mainly osteoarthritis and disc degeneration. It also provides cell therapy platform for tissue repair protection with an entirely new arsenal of various anti-inflammatory and anti-autoimmune formulations using the immunomodulatory properties of ATO/OATO (Arsenic trioxide/ Oral arsenic trioxide).

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Chief Executive Officer FrancoisRieger 79 10/24/2022 10/24/2022
Deputy Chief Executive Officer, Executive Director VeroniquePomi Schneiter 58 10/24/2022 10/24/2022
Chief Medical Officer LievenHuysse 54 4/3/2023 4/3/2023
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Medsenic 204 Avenue De Colmar Strasbourg France

Business Names
Business Name
0R55
BIOS
Bone Therapeutics USA Inc.
BOTHE
Medsenic

General Information
Number of Employees: 11 (As of 12/31/2023)
Outstanding Shares: 265,598,531 (As of 10/7/2024)
Stock Exchange: EBR
Fax Number: +32 71121001


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024